ARCT: Arcturus Therapeutics Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 967.65
Enterprise Value ($M) 675.73
Book Value ($M) 280.06
Book Value / Share 10.48
Price / Book 3.46
NCAV ($M) 215.68
NCAV / Share 8.07
Price / NCAV 4.49

Profitability (mra)
Return on Invested Capital (ROIC) 0.30
Return on Assets (ROA) 0.22
Return on Equity (ROE) 0.37

Liquidity (mrq)
Quick Ratio 4.49
Current Ratio 4.49

Balance Sheet (mrq) ($M)
Current Assets 393.27
Assets 457.65
Liabilities 177.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
9 days ago 13G/A Vanguard Group Inc 5.46 0.55
02-12 13G/A Nikko Asset Management Americas, Inc. 4.94 -8.86
02-05 13G/A Sumitomo Mitsui Trust Holdings, Inc. 4.94 -8.86
01-29 13G/A ARK Investment Management LLC 7.66 1.75
01-25 13G/A State Street Corp 6.10 -2.29
01-25 13G/A BlackRock Inc. 9.00 27.24
01-17 13G/A Federated Hermes, Inc. 17.63 11.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-21 44,565 289,858 15.37
2024-02-20 60,910 396,724 15.35
2024-02-16 49,458 340,304 14.53

(click for more detail)

Similar Companies
APGE – Apogee Therapeutics, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc. ARDX – Ardelyx, Inc.
ATAI – Atai Life Sciences N.V.


Financial data and stock pages provided by
Fintel.io